High Points and Hurdles: Immunotherapy Moves Forward

Anita T. Shaffer @Shaffer1
Published: Wednesday, Jun 27, 2012
T lymphocytes attacking a migrating cancer cell

Illustration depicts T lymphocytes attacking a migrating cancer cell. Novel ways to improve the ability of T lymphocytes to enhance immune response are under study.

At this time last year, immunotherapy was in the limelight. Within a span of less than 12 months, the FDA had approved the first anticancer therapeutic vaccine and an antibody with a unique mechanism of action. Advocates of cancer-fighting immune strategies felt vindicated after facing skepticism and disappointment.
Today, immunotherapy is maintaining its momentum in clinical development programs, with explorations under way in many tumor types, including breast and lung cancers previously considered poor candidates for such modalities.

Dr. Mary L. Disis

Mary L. (Nora) Disis, MD



Professor, Medicine and Oncology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA

Mary L. Disis, MD, is a chief co-investigator of the Cancer Immunotherapy Trials Network (CITN), which links researchers at 27 institutions with the intention of creating a pipeline of agents that can move into advanced trials. The National Cancer Institute launched the network in April 2011, designating the Fred Hutchinson Cancer Research Center as its headquarters.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2019
Intellisphere, LLC. All Rights Reserved.
 
x